Mastologia

Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial.

Lancet (London, England). 2026 Jan; 407(Jan):505-514. doi: 10.1016/S0140-6736(25)02464-X. pii: S0140-6736(25)02464-X.

ASO Visual Abstract: Axillary Management in Patients with Breast Cancer with Positive Lymph Nodes Following Neoadjuvant Chemotherapy.

Annals of surgical oncology. 2026 Jan; doi: 10.1245/s10434-025-19036-4. pii: .

Menopausal hormone therapy for breast cancer patients: what is the current evidence?

Menopause (New York, N.Y.). 2026 Jan; 33(Jan):88-117. doi: 10.1097/GME.0000000000002627. pii: .

Breast Arterial Calcifications in Mammography: Evaluating Diagnostic Accuracy, Reproducibility, and Clinical Feasibility of Visual Scoring Systems.

Journal of breast imaging. 2026 Feb; doi: 10.1093/jbi/wbaf069. pii: wbaf069.

The role of regional nodal irradiation in clinically node-positive breast cancer patients who undergo neoadjuvant chemotherapy and breast-conserving surgery.

Breast cancer research and treatment. 2026 Feb; 216(Feb):14. doi: 10.1007/s10549-026-07914-8. pii: .

De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practice.

Cancer treatment reviews. 2026 Feb; 143(Feb):103092. doi: 10.1016/j.ctrv.2026.103092. pii: S0305-7372(26)00006-X.

Optimal time to surgery post-neoadjuvant chemotherapy: lessons from recent evidence and historical patterns.

Breast cancer research and treatment. 2026 Feb; 216(Feb):13. doi: 10.1007/s10549-026-07924-6. pii: .

Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer.

The New England journal of medicine. 2026 Jan; 394(Jan):451-462. doi: 10.1056/NEJMoa2511218. pii: .

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

The New England journal of medicine. 2026 Jan; 394(Jan):354-366. doi: 10.1056/NEJMoa2508959. pii: .

Adjuvant Chemotherapy in Breast Cancer after Neoadjuvant Therapy: Essential or Optional?

Cancer research and treatment. 2026 Jan; 58(Jan):208-220. doi: 10.4143/crt.2024.1254. pii: .

Oncologic safety of prophylactic nipple-sparing mastectomy: Outcomes of 1,255 cases exceeding a 6-year median follow-up.

Breast cancer research and treatment. 2026 Feb; 215(Feb):72. doi: 10.1007/s10549-026-07907-7. pii: .

Fertility preservation in breast cancer patients: a systematic review and summary of current evidence and recommendations.

Breast cancer research and treatment. 2026 Feb; 215(Feb):68. doi: 10.1007/s10549-026-07901-z. pii: .

Breast Surgical Perspectives on the NSABP B-51/RTOG 1304 Trial on Omission of Regional Nodal Irradiation After Response to Neoadjuvant Chemotherapy.

Annals of surgical oncology. 2026 Jan; doi: 10.1245/s10434-025-18989-w. pii: .

Imaging biomarkers are key to recognizing fatal breast cancers arising in the major ducts.

European journal of radiology. 2026 Feb; 195(Feb):112564. doi: 10.1016/j.ejrad.2025.112564. pii: S0720-048X(25)00650-3.

Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants: A Systematic Review and Meta-Analysis.

JAMA surgery. 2026 Jan; doi: 10.1001/jamasurg.2025.5929. pii: .

Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial.

BMJ (Clinical research ed.). 2026 Jan; 392(Jan):s43. doi: 10.1136/bmj.s43. pii: .

Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently.

Breast cancer research and treatment. 2026 Jan; 215(Jan):54. doi: 10.1007/s10549-025-07888-z. pii: .

Joint guideline update recommendations for postmastectomy radiation therapy: The guideline task force identified several key radiation therapy questions for patients with breast cancer who undergo mastectomy.

Cancer. 2026 Jan; 132(Jan):e70178. doi: 10.1002/cncr.70178. pii: .

Evaluation of Breast Volume following Lumpectomy Combined with Oncoplastic Reduction Mammaplasty and Radiation Therapy.

Plastic and reconstructive surgery. 2026 Jan; 157(Jan):32-40. doi: 10.1097/PRS.0000000000012309. pii: .

FDA and EMA approval of datopotamab-deruxtecan: A paradigm shift in breast cancer drug evaluation?

Breast (Edinburgh, Scotland). 2025 Dec; 84(Dec):104589. doi: 10.1016/j.breast.2025.104589. pii: 104589.

Quantitative angiogenesis-based ultrasound biomarkers for differentiating radiologically challenging breast lesions: Radial scar vs invasive ductal carcinoma.

Breast (Edinburgh, Scotland). 2025 Dec; 84(Dec):104614. doi: 10.1016/j.breast.2025.104614. pii: 104614.

Differences in Treatment and Survival for Secondary Triple Negative Breast Cancer in Premenopausal Women.

Annals of surgical oncology. 2026 Jan; doi: 10.1245/s10434-025-18892-4. pii: .

Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer.

The New England journal of medicine. 2025 Nov; 393(Nov):1771-1783. doi: 10.1056/NEJMoa2412225. pii: .

Imaging Surveillance and Risk-Based Management of Known Genetic Mutations in Breast Cancer: A Radiologist's Guide.

Journal of breast imaging. 2025 Dec; 7(Dec):636-652. doi: 10.1093/jbi/wbaf054. pii: .

Factors Associated With Residual Disease on Re-Excision Specimens After Breast-Conserving Surgery for Breast Cancer.

Annals of surgical oncology. 2025 Dec; doi: 10.1245/s10434-025-18813-5. pii: .

International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-low and Ultralow Categories.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2025 Oct; 100925. doi: 10.1016/j.modpat.2025.100925. pii: S0893-3952(25)00223-6.

ACR Appropriateness Criteria® Female Breast Cancer Screening: 2025 Update.

Journal of the American College of Radiology : JACR. 2025 Nov; 22(Nov):S508-S530. doi: 10.1016/j.jacr.2025.08.044. pii: S1546-1440(25)00498-3.

Pregnancy and Breast Cancer: Green-top Guideline No. 12.

BJOG : an international journal of obstetrics and gynaecology. 2025 Nov; 132(Nov):e194-e228. doi: 10.1111/1471-0528.18270. pii: .

American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions.

JAMA surgery. 2025 Oct; doi: 10.1001/jamasurg.2025.4392. pii: .

Recommendations From the Women's Preventive Services Initiative on Breast Cancer Screening for Women at Average Risk and Patient Navigation Services for Breast and Cervical Cancer Screening.

Obstetrics and gynecology. 2025 Jul; 146(Jul):315-322. doi: 10.1097/AOG.0000000000006011. pii: .

AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2025 Nov; 51(Nov):110445. doi: 10.1016/j.ejso.2025.110445. pii: S0748-7983(25)00873-X.

FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research. 2025 Nov; 31(Nov):4405-4411. doi: 10.1158/1078-0432.CCR-25-1388. pii: .

Consensus document on preoperative diagnostic procedures in breast lesions.

Pathologica. 2025 Jun; 117(Jun):178-198. doi: 10.32074/1591-951X-1113. pii: .

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025.

Breast care (Basel, Switzerland). 2025 Mar; 1-12. doi: 10.1159/000545018. pii: .

Age to Initiate Routine Breast Cancer Screening: ACOG Clinical Practice Update.

Obstetrics and gynecology. 2025 Jan; 145(Jan):e40-e44. doi: 10.1097/AOG.0000000000005757. pii: .

Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 1: The role of common errors in radiology in missed breast cancer and implications of misdiagnosis.

European radiology. 2024 Nov; doi: 10.1007/s00330-024-11128-1. pii: .

Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 2: Main causes of errors in breast imaging and recommendations from European Society of Breast Imaging to limit misdiagnosis.

European radiology. 2024 Nov; doi: 10.1007/s00330-024-11133-4. pii: .

Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations.

Cancer. 2024 Oct; 130(Oct):3251-3271. doi: 10.1002/cncr.35389. pii: .

Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines.

Breast (Edinburgh, Scotland). 2024 Dec; 78(Dec):103806. doi: 10.1016/j.breast.2024.103806. pii: 103806.

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology. 2023 Aug; 34(Aug):645-659. doi: 10.1016/j.annonc.2023.05.008. pii: S0923-7534(23)00693-2.

Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer.

Annals of surgical oncology. 2024 Sep; 31(Sep):5479-5482. doi: 10.1245/s10434-024-15638-6. pii: .

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).

Breast (Edinburgh, Scotland). 2024 Aug; 76(Aug):103756. doi: 10.1016/j.breast.2024.103756. pii: 103756.

Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Jul; 22(Jul):331-357. doi: 10.6004/jnccn.2024.0035. pii: .

Intensity Modulated Therapy for Patients With Breast Cancer. Practical Guidelines and Tips for an Effective Treatment Planning Strategy.

Advances in radiation oncology. 2024 Aug; 9(Aug):101535. doi: 10.1016/j.adro.2024.101535. pii: 101535.

Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline.

Practical radiation oncology. 2024 ; 14():112-132. doi: 10.1016/j.prro.2023.11.001. pii: S1879-8500(23)00296-5.

Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities.

Annals of surgical oncology. 2024 Oct; 31(Oct):7326-7334. doi: 10.1245/s10434-024-15713-y. pii: .

Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Feb; 42(Feb):584-604. doi: 10.1200/JCO.23.02225. pii: .

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology. 2024 Feb; 35(Feb):159-182. doi: 10.1016/j.annonc.2023.11.016. pii: S0923-7534(23)05104-9.

Challenges of breast cancer screening.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2023 Sep; 45(Sep):551-554. doi: 10.1055/s-0043-1775931. pii: .

Challenges of breast cancer screening.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2023 Oct; 45(Oct):622-625. doi: 10.1055/s-0043-1776716. pii: .

The role of regional nodal irradiation in clinically node-positive breast cancer patients who undergo neoadjuvant chemotherapy and breast-conserving surgery.

Breast cancer research and treatment. 2026 Feb; 216(Feb):14. doi: 10.1007/s10549-026-07914-8. pii: .

Optimal time to surgery post-neoadjuvant chemotherapy: lessons from recent evidence and historical patterns.

Breast cancer research and treatment. 2026 Feb; 216(Feb):13. doi: 10.1007/s10549-026-07924-6. pii: .

Breast Arterial Calcifications in Mammography: Evaluating Diagnostic Accuracy, Reproducibility, and Clinical Feasibility of Visual Scoring Systems.

Journal of breast imaging. 2026 Feb; doi: 10.1093/jbi/wbaf069. pii: wbaf069.

Diagnostic accuracy of tumor bed biopsy for predicting pathological complete response in breast cancer patients achieving clinical complete response after neoadjuvant chemotherapy: a meta-analysis.

Breast cancer research and treatment. 2026 Feb; 215(Feb):75. doi: 10.1007/s10549-026-07916-6. pii: .

Oncologic safety of prophylactic nipple-sparing mastectomy: Outcomes of 1,255 cases exceeding a 6-year median follow-up.

Breast cancer research and treatment. 2026 Feb; 215(Feb):72. doi: 10.1007/s10549-026-07907-7. pii: .

Fertility preservation in breast cancer patients: a systematic review and summary of current evidence and recommendations.

Breast cancer research and treatment. 2026 Feb; 215(Feb):68. doi: 10.1007/s10549-026-07901-z. pii: .

Imaging biomarkers are key to recognizing fatal breast cancers arising in the major ducts.

European journal of radiology. 2026 Feb; 195(Feb):112564. doi: 10.1016/j.ejrad.2025.112564. pii: S0720-048X(25)00650-3.

De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practice.

Cancer treatment reviews. 2026 Feb; 143(Feb):103092. doi: 10.1016/j.ctrv.2026.103092. pii: S0305-7372(26)00006-X.

Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial.

Lancet (London, England). 2026 Jan; 407(Jan):505-514. doi: 10.1016/S0140-6736(25)02464-X. pii: S0140-6736(25)02464-X.

Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer.

The New England journal of medicine. 2026 Jan; 394(Jan):451-462. doi: 10.1056/NEJMoa2511218. pii: .